Skye Bioscience to Present at the H.C. Wainwright Ophthalmology Conference
SAN DIEGO, CA, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary,...
News
BioRestorative Therapies Discusses Upcoming Annual Meeting of Stockholders
MELVILLE, N.Y., Aug. 11, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences...
Biomerica Announces Notice of Allowance for Patent on Product used to Diagnose and Treat Depression
Hundreds of millions of people worldwide suffer from depressionIRVINE, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA)...
Vallon Pharmaceuticals to Present at the Q3 Virtual Investor Summit
Live video webcast with David Baker, President and CEO of Vallon, on Wednesday, August 18th12:30 PM ET PHILADELPHIA, PA, Aug....
Outlook Therapeutics to Participate at the H.C. Wainwright Ophthalmology Virtual Conference
Russell Trenary, President and Chief Executive Officer of Outlook Therapeutics, to participate in The Greatest Unmet Needs Facing Ophthalmology Today...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 10 August 2021
Bagsværd, Denmark, 11 August 2021 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares...
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2021
Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports...
Tecan schedules conference call on August 18th to discuss half year 2021 financial results
Männedorf, Switzerland, August 11, 2021 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to...
Nasdaq Grants Advaxis, Inc. an Extension to November 22, 2021, to Regain Compliance with the $1.00 Minimum Bid Price Rule and Complete Merger Transaction with Biosight, Ltd.
MONMOUTH JUNCTION, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS) (“Advaxis” or the “Company”), a clinical-stage biotechnology...
IN8bio Completes Dosing of First Cohort in Phase 1 Clinical Trial with Allogeneic Gamma Delta T-Cell Therapy in Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant
The first cohort has completed dosing with IN8bio’s donor derived allogeneic gamma delta T-cell product candidate, INB-100, with no severe...
Zivo Bioscience to Present at Two Upcoming August Conferences
KEEGO HARBOR, Mich., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO), a biotech/agtech R&D company engaged in...
Quipt Home Medical Corp. to Report Third Quarter 2021 Financial Results on August 23, 2021
CINCINNATI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the...
AcQMap 8, Acutus Medical’s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark
Enhanced Software Automatically Identifies Regions of Interest During the Treatment of Complex Atrial Arrhythmias AcQMap 8 Software with AcQTrack™ and...
Summit Therapeutics Provides Update on Ri-CoDIFy Trials
Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Based on a thorough review of the design and enrollment status of...
RAPT Therapeutics Reports Second Quarter 2021 Financial Results
SOUTH SAN FRANCISCO, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused...
BrainsWay Reports Second Quarter 2021 Financial Results and Operational Highlights
Strong Revenue Growth of 45% Year-over-Year in Q2 2021 Gained Meaningful Traction in Reimbursement for Deep TMS™ in both OCD...
Avera Health and Sema4 Announce Collaboration to Advance Precision Oncology Care
Building on its commitment to genomic research and healthcare innovations, Avera Health will utilize Sema4’s health intelligence platform to further advance...
Quotient Limited Announces Departure of Chief Commercial Officer, Jeremy Stackawitz
JERSEY, Channel Islands, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), announced that...
Diffusion Pharmaceuticals Reports Q2 Financial Results and Provides Business Update
Reports Improved Outcomes in Phase 1b COVID-19 Study and Positive Trend in Peripheral Oxygenation in Phase 1b TCOM StudyExpects to Announce...
Avicanna Enters Partnership with Heritage Cannabis Holdings Corp. to Commercialize Evidence-Based Topical Products through Heritage’s Medical Cannabis Channels
Exclusive licensing of certain of Avicanna’s advanced and evidence-based CBD topical products including its deep tissue and skin care formulations.Heritage...
